Advancement of Antihyperglycemic Therapy: The Management of Type 2 Diabetes is evolving with new data (Mainpro)

EU

$0

free

Mainpro+

1 hr

Endocrinology

1 Credits

This course is expired! Browse All Courses
LEARN MORE

Course Description

This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.

Course Details

Expiry Date: 2022-09-14

Professions: Physician, Nursing, Specialist

Faculty

Peter Lin, MD, CCFP (moderator)

Kim Connelly, MBBS PhD FSCMR FCCS

Roopa Mehta, MBBS, MRCP

Dipesh Patel, BSc, MBBS PhD, MRCP

Dirk Pilat, FRCGP, PgDipGP, BSc

David Strain, MBChB MD FRCP

Rene Wong, MD, FRCPC, MEd

Accreditation

Learning Objective(s)

  1. Discuss the frequency and factors associated with therapeutic inertia in type 2 diabetes
  2. Review the evolving management of type 2 diabetes beyond simply glycemic control but a reduction in both micro and macrovascular complications
  3. Review what may be triggers for treatment escalation
    1. HbA1c rising
    2. Progression of microvascular disease
    3. Atherosclerotic event
    4. New diagnosis of heart failure or CKD
This course is expired! Browse All Courses